» Articles » PMID: 37638448

Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1

Overview
Publisher Sage Publications
Specialty Neurology
Date 2023 Aug 28
PMID 37638448
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myotonic dystrophy type 1 (DM1) is a dominant autosomal neuromuscular disorder caused by the inheritance of a CTG triplet repeat expansion in the Dystrophia Myotonica Protein Kinase (DMPK) gene. At present, no cure currently exists for DM1 disease.

Objective: This study investigates the effects of 12-week resistance exercise training on mitochondrial oxidative phosphorylation in skeletal muscle in a cohort of DM1 patients (n = 11, men) in comparison to control muscle with normal oxidative phosphorylation.

Methods: Immunofluorescence was used to assess protein levels of key respiratory chain subunits of complex I (CI) and complex IV (CIV), and markers of mitochondrial mass and cell membrane in individual myofibres sampled from muscle biopsies. Using control's skeletal muscle fibers population, we classified each patient's fibers as having normal, low or high levels of CI and CIV and compared the proportions of fibers before and after exercise training. The significance of changes observed between pre- and post-exercise within patients was estimated using a permutation test.

Results: At baseline, DM1 patients present with significantly decreased mitochondrial mass, and isolated or combined CI and CIV deficiency. After resistance exercise training, in most patients a significant increase in mitochondrial mass was observed, and all patients showed a significant increase in CI and/or CIV protein levels. Moreover, improvements in mitochondrial mass were correlated with the one-repetition maximum strength evaluation.

Conclusions: Remarkably, 12-week resistance exercise training is sufficient to partially rescue mitochondrial dysfunction in DM1 patients, suggesting that the response to exercise is in part be due to changes in mitochondria.

Citing Articles

New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.

Legare C, Berglund J, Duchesne E, Dumont N Bioessays. 2024; 47(3):e202400216.

PMID: 39723693 PMC: 11848125. DOI: 10.1002/bies.202400216.


Physiotherapeutic Interventions for Patients With Rare Genetic Muscle-Wasting Disorders: A Systematic Review and Meta-Analysis.

Alzahrani A Cureus. 2024; 16(8):e66349.

PMID: 39247036 PMC: 11377964. DOI: 10.7759/cureus.66349.


Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.

Roussel M, Ravel-Chapuis A, Gobin J, Jasmin B, Leduc-Gaudet J, Gagnon C J Neuromuscul Dis. 2024; 11(5):981-995.

PMID: 39031377 PMC: 11380274. DOI: 10.3233/JND-230139.


Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration.

Yadava R, Mandal M, Mahadevan M Int J Mol Sci. 2024; 25(5).

PMID: 38473933 PMC: 10931579. DOI: 10.3390/ijms25052687.

References
1.
Gagnon C, Petitclerc E, Kierkegaard M, Mathieu J, Duchesne E, Hebert L . A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1. J Neurol. 2018; 265(7):1698-1705. DOI: 10.1007/s00415-018-8898-4. View

2.
Ueda H, Shimokawa M, Yamamoto M, Kameda N, Mizusawa H, Baba T . Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy. J Neurol Sci. 1999; 162(1):38-50. DOI: 10.1016/s0022-510x(98)00290-1. View

3.
Panaite P, Gantelet E, Kraftsik R, Gourdon G, Kuntzer T, Barakat-Walter I . Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves. J Neuropathol Exp Neurol. 2008; 67(8):763-72. DOI: 10.1097/NEN.0b013e318180ec64. View

4.
Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S . Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018; 17(8):671-680. DOI: 10.1016/S1474-4422(18)30203-5. View

5.
Mikhail A, Nagy P, Manta K, Rouse N, Manta A, Ng S . Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes. J Clin Invest. 2022; 132(10). PMC: 9106360. DOI: 10.1172/JCI156125. View